We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Published in Oncology

Journal Scan / Research · September 27, 2012

Heterogeneous FDG–PET Responses Prognostic in Dabrafenib-Treated Metastatic Melanoma

European Journal of Cancer

 

Additional Info

European Journal of Cancer
18F-Labelled Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Heterogeneity of Response is Prognostic in Dabrafenib Treated BRAF Mutant Metastatic Melanoma
Eur. J. Cancer 2012 Sep 17;()2012 Sept 17, MS Carlino, CAB Saunders, LE Haydu, et al

Further Reading